Sealand Capital – Exercise of Warrants, Issue of Equity and TVR
SCGL
RNS Number : 2254S Sealand Capital Galaxy Limited 27 August 2026
Information contained within this announcement is deemed by the Company to constitute inside information as stipulated under Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon publication of this announcement, this inside information is now considered to be in the public domain
Sealand Capital Galaxy Limited
(“Sealand” or the “Company”)
Exercise of Warrants, Issue of Equity and Total Voting Rights
Sealand Capital Galaxy LimitedSCGL, a technology-focused company developing, acquiring and operating businesses across high-growth digital and AI markets, with a particular focus on Asia, today announces that it has raised approximately £4.94 million through the exercise of Conversion A Warrants by nine investors
Exercise of Conversion A Warrants
The Company announces that it has received notices from nine investors to exercise, in aggregate, 1,646,571,480 Conversion A Warrants, each exercisable at £0.0030 per ordinary share of £0.0001 each in the capital of the Company (“Ordinary Shares”), resulting in the allotment and issue of 1,646,571,480 new Ordinary Shares (the “Warrant Shares”), and raising aggregate gross proceeds of approximately £4,939,714 for the Company (the “Warrant Exercises”)
The Conversion A Warrants were granted pursuant to the terms of the Company’s convertible loan note instrument, upon conversion of the convertible loan notes, as set out in the Company’s announcement of 30 March 2026. Each Conversion A Warrant entitles the holder to subscribe for one new Ordinary Share at an exercise price of £0.0030 and is exercisable for a period of two years from the date of grant. The exercise notices were received from the relevant warrant holders on a number of dates during July and August 2026 and subscription monies of £4,939,714.44 have been received in full by the Company.
None of the exercising warrant holders is a director of, or other person discharging managerial responsibilities within, the Company, nor a related party of the Company for the purposes of the Disclosure Guidance and Transparency Rules (“DTR”)
Use of Proceeds
The net proceeds from the Warrant Exercises will further strengthen the Company’s balance sheet and provide additional working capital to support the continued execution of Sealand’s investment and growth strategy. In particular, the additional capital will provide the Company with greater flexibility to evaluate and pursue investment opportunities in line with its stated focus on technology and AI-related businesses
Outstanding Warrants
Following the Warrant Exercises, 1,678,806,981 Conversion A Warrants remain outstanding, of which 979,849,931 are held by Mr. Siqi Cao, Chief Executive Officer of the Company. The 4,237,254,794 Conversion B Warrants, each exercisable at £0.00375 per Ordinary Share, are unaffected by the Warrant Exercises and remain outstanding in full
Admission and Total Voting Rights
Application will be made for the Warrant Shares to be admitted to the Equity Shares (transition) category of the Official List and to trading on the main market of the London Stock Exchange plc (“Admission”). It is expected that Admission will become effective and that dealings in the Warrant Shares will commence at 8.00 a.m. on or around 2 September 2026. The Warrant Shares will, on Admission, rank pari passu in all respects with the existing Ordinary Shares
The Warrant Shares will be allotted and issued pursuant to the authority granted to the Directors at the General Meeting held on 26 March 2026, pursuant to Resolutions 2 and 3 passed at that meeting, under which the Directors were authorised to allot up to 27,000,000,000 new Ordinary Shares and to disapply statutory pre-emption rights in respect of such allotments
Following Admission, the total issued share capital of the Company will consist of 8,193,979,829 Ordinary Shares, each carrying one voting right. There are no shares held in treasury
This figure of 8,193,979,829 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the DTR
Siqi Cao, Chief Executive Officer of Sealand, commented:
“The exercise of these warrants provides Sealand with a further £4.94 million of capital and significantly strengthens our financial position as we continue to execute our growth strategy
“We are continuing to evaluate a number of opportunities across our target sectors and this additional capital gives us greater flexibility to pursue those opportunities where we believe they can create long-term value for shareholders. We are grateful for the continued support of our investors and look forward to updating shareholders on our progress.”
The Directors of the Company are responsible for the release of this announcement
-ends-
Enquiries:
Sealand Capital Galaxy Limited
Ms. Elena Suet Sum Law (Chairwomen)
Mr. Siqi Cao (Chief Executive Officer)
Mr. Geoffrey Griggs (Non-Executive Director)
Mr. Chong Sun Terng (Non-Executive Director)
Ms. Daphne Zhang (Non-Executive Director)
SPARK Advisory Partners Limited (Financial Adviser) +44 (0) 203 368 3550/3551
Mark Brady / Angus Campbell
Investor Relations and Media
media@scglimited.info
Notes to Editors:
The Company’s shares are traded on the Equity shares (transition) category of the London Stock Exchange under ticker LSE: SCGL
Further information on Sealand Capital Galaxy Limited is available on: www.sealandcapitalgalaxy.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END MSCPFMPTMTBTMJF
Read the full articleCreate a free account to access this article and thousands more published daily.
